BrainStorm Cell Therapeutics Inc. (BCLI) stock
BCLIOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.77−0.01 (-1.17%)
Close on Oct 19, 2026Market cap $8.50MP/E –Yield –
BrainStorm Cell Therapeutics net income
Net income is the profit left for shareholders after every expense, interest and tax.
BrainStorm Cell Therapeutics's net income for the twelve months ending Jun 30, 2026 was -$10.52M. For fiscal 2025 it was -$10.31M. The highest annual figure on record is -$26.00K in fiscal 2002.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.31M | – |
| FY2024 | Dec 31, 2024 | -$11.62M | – |
| FY2023 | Dec 31, 2023 | -$17.19M | – |
| FY2022 | Dec 31, 2022 | -$24.28M | – |
| FY2021 | Dec 31, 2021 | -$24.46M | – |
| FY2020 | Dec 31, 2020 | -$31.81M | – |
| FY2019 | Dec 31, 2019 | -$23.25M | – |
| FY2018 | Dec 31, 2018 | -$13.95M | – |
| FY2017 | Dec 31, 2017 | -$4.95M | – |
| FY2016 | Dec 31, 2016 | -$4.98M | – |
| FY2015 | Dec 31, 2015 | -$8.49M | – |
| FY2014 | Dec 31, 2014 | -$9.25M | – |
| FY2013 | Dec 31, 2013 | -$4.90M | – |
| FY2012 | Dec 31, 2012 | -$3.43M | – |
| FY2011 | Dec 31, 2011 | -$3.92M | – |
| FY2010 | Dec 31, 2010 | -$2.42M | – |
| FY2009 | Dec 31, 2009 | -$1.78M | – |
| FY2008 | Dec 31, 2008 | -$3.47M | – |
| FY2006 | Mar 31, 2006 | -$3.32M | – |
| FY2005 | Mar 31, 2005 | -$18.84M | – |
| FY2004 | Mar 31, 2004 | -$73.00K | – |
| FY2003 | Mar 31, 2003 | -$47.00K | – |
| FY2002 | Mar 31, 2002 | -$26.00K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.86M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.13M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.43M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.11M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.90M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.86M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.97M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.71M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.54M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.40M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.58M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.23M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.33M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.06M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.02M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.86M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.04M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.36M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.19M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.34M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.27M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.66M | – |
| Q4 FY2020 | Dec 31, 2020 | -$11.82M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.49M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.39M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.11M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.69M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.63M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.90M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.03M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.38M | -2050.4% |
| Q3 FY2018 | Sep 30, 2018 | -$3.18M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.09M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.30M | – |
| Q4 FY2017 | Dec 31, 2017 | $276.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.40M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.04M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.79M | – |
| Q4 FY2016 | Dec 31, 2016 | -$624.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.61M | – |
See a number that looks wrong?